A corresponding therapeutic strategy for macrophage‐targeted JMJD3 suppression promotes diabetic wound healing by ameliorating persistent inflammation.[53, 54, 55] Although ATP‐dependent chromatin remodeling has been demonstrated to be critical for metabolic disease, there is a paucity of these regulatory functions in diabetes or wound healing.[56]. This evidence concerns the gene KDM6B and Other metabolic disease.